Archive for October, 2013
-
The narrow therapeutic window of ribavirin as an inhibitor of nitric oxide synthesis is broadened by macromolecular prodrugs
Our newest publication, demonstrating how macromolecular prodrugs broaden the therapeutic window of the associated drug, has been published in Biomacromolecules.
![Our work on “Molecular, Macromolecular, and Supramolecular Glucuronide Prodrugs: Lead Identified for Anticancer Prodrug Monotherapy” has been recently published in Angewande Chemie. In this work, a tumor growth intervention by […]](http://www.zelikin-lab.com/wp-content/uploads/2020/03/Artboard-3_TOC_MacroGlucuronides_-36x36.png "New publication: Angewandte Chemie"){kind=small}